In this new ESOU Online programme moderated by Prof. Rouprêt, experts discuss the latest developments in kidney cancer. We have Prof. Bex giving a state-of-the-art lecture on current RCC trials and what’s new in the EAU2022 RCC guidelines, Dr. Kuusk presenting a case on adjuvant treatments and recurrent disease, and finally, Prof. Albiges elaborates on what’s in the pipeline in the field of medical treatment of RCC.
This activity is supported by an educational grant from a pharmaceutical company, with no involvement in the programme or speaker selection.